• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Monday, October 15, 2018

    Offline Date

    Wednesday, May 1, 2019

    ACPE Expiration Date

    Friday, August 27, 2021

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      More than 10 million patients visit their physician every year for heart failure. More patients require hospitalization for heart failure than all types of cancer combined. Heart failure usually gets worse with time and approximately 50% of patients with heart failure die within 5 years. Pharmacist involvement in the management of chronic heart failure can improve quality of life and minimize hospitalization. This knowledge-based activity will review the recommendations and updated pharmacotherapy for heart failure to include appropriate candidates, relevant drug interactions and monitoring parameters. Further, the activity will offer pharmacists strategies for educating patients on treatment and encouraging compliance with drug and diet therapy as part of the health care team to reduce further hospitalizations and improve patient outcomes.

      Handouts

      • Slide Document :   18111H01_4pp.pdf
      • Slide Document :   18111H01_2pp.pdf

      Financial Support By

      Novartis
    • Pharmacist

      Describe the current and emerging pharmacotherapies for patients with heart failure with reduced ejection fraction (HFrEF) to include their role in therapy, adverse events, safety concerns, and key counseling points associated with each.
      Outline the key changes/recommendations identified in the 2017 ACCF/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guidelines for the Management of Heart Failure.
      Identify the pharmacist’s role in educating patients on the importance of HF prevention, hypertension management, and the treatment of comorbid conditions related to managing heart failure.

      Nurse

      Describe the current and emerging pharmacotherapies for patients with heart failure with reduced ejection fraction (HFrEF) to include their role in therapy, adverse events, safety concerns, and key counseling points associated with each.
      Identify the pharmacist’s role in educating patients on the importance of HF prevention, hypertension management, and the treatment of comorbid conditions related to managing heart failure.
      Outline the key changes/recommendations identified in the 2017 ACCF/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guidelines for the Management of Heart Failure.
    • Activity Type

      Knowledge

      CE Broker

      20-626517

      Universal Activity Number

      Pharmacist 0798-0000-18-111-H01-P
      Nurse 0798-0000-18-111-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).